Segment Information (Tables)

9 Months Ended

Jun. 30, 2021

Segment Reporting [Abstract]

Segment Revenue, Operating (Loss) Income and Depreciation and Amortization

Segment revenue, operating (loss) income, and depreciation and amortization were as follows:

	Three Months Ended						Nine Months Ended
	June 30,						June 30,
(In thousands)	2021			2020			2021			2020
Revenue:
Medical Device	$	16,755		$	20,514		$	60,858		$	54,222
In Vitro Diagnostics		7,118			6,369			20,307			18,099
Total revenue	$	23,873		$	26,883		$	81,165		$	72,321
Operating (loss) income:
Medical Device	$	(2,491	)	$	532		$	5,480		$	(1,344	)
In Vitro Diagnostics		3,378			3,254			10,407			9,315
Total segment operating income		887			3,786			15,887			7,971
Corporate		(3,271	)		(2,622	)		(8,695	)		(7,229	)
Total operating (loss) income	$	(2,384	)	$	1,164		$	7,192		$	742
Depreciation and amortization:
Medical Device	$	1,631		$	1,424		$	5,004		$	4,318
In Vitro Diagnostics		121			112			314			331
Corporate		92			254			292			741
Total depreciation and amortization	$	1,844		$	1,790		$	5,610		$	5,390